Mycocept 250 250 mg Capsules
PDF Leaflet Revision Date: 14 May 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylaxis of acute transplant rejection in renal, cardiac, and hepatic transplants.
Dosage (summary)
Adults: 1 g orally twice daily for renal; 1.5 g twice daily for cardiac and hepatic transplants.
Onset of Action / Duration
Onset: 72 hours post-transplant, Duration: Not specified
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding; teratogenic effects noted.
Key Drug Interactions
- Caution with ciclosporin, cholestyramine, antibiotics
- Avoid azathioprine
Contraindications
- Hypersensitivity to mycophenolate mofetil
- Pregnancy
- Breastfeeding
Common side effects
- Leukopenia
- Sepsis
- Diarrhoea
- Vomiting
Counselling Points
- Use effective contraception
- Report infections or unusual bleeding
- Avoid live vaccines
Serious warnings
- Increased risk of malignancies
- Opportunistic infections
- Teratogenicity
Important Disclaimer
The Mycocept 250 250 mg Capsules professional information leaflet below is the property of Sandoz Sa 1 and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
